$1.50
0.074.9%
Serina Therapeutics Inc
SERAMEX
Serina Therapeutics fell 63.2% from $4.08 to $1.50, behind the S&P 500's +11.2%. Its worst day was Mar 24 (−22.9%), and its low came Mar 18 at $1.28.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.45 beat the $-0.51 estimate on $0.00 revenue.
−2.5% · S&P 500 −1.7%
Serina Therapeutics closed at its highest level of the year, 4.4% above where the year started.
Story events cover the past 12 months · Times ET
+9.0% · S&P 500 +0.5%
Serina Therapeutics shares rose 30.1%, while the S&P 500 fell 0.2%.
+30.1% · S&P 500 −0.2%
Serina Therapeutics closed at its lowest level of the year, 68.6% below where the year started.
−4.5% · S&P 500 −1.4%
EPS of $-0.31 beat the $-0.47 estimate on $0.00 revenue.
−13.9% · S&P 500 −1.8%
EPS of $-0.58 missed the $-0.44 estimate on $0.00 revenue.
−4.7% · S&P 500 −1.2%
EPS of $-0.55 missed the $-0.35 estimate on $130,000.00 revenue.
−1.8% · S&P 500 −0.2%
Where it ended: a close of $1.50 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.34).
Nothing in the past 12 months.
All SER dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SER and SPY from Benzinga historical bars. Not investment advice.
